These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35801335)

  • 1. Analysing transmission dynamics of HIV/AIDS with optimal control strategy and its controlled state.
    Wattanasirikosone R; Modnak C
    J Biol Dyn; 2022 Dec; 16(1):499-527. PubMed ID: 35801335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the transmission dynamics and optimal control strategies for HIV infection in China.
    Xue L; Sun Y; Ren X; Sun W
    J Biol Dyn; 2023 Dec; 17(1):2174275. PubMed ID: 36787262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Solution of a Fractional HIV/AIDS Epidemic Mathematical Model.
    Hassani H; Avazzadeh Z; Machado JAT; Agarwal P; Bakhtiar M
    J Comput Biol; 2022 Mar; 29(3):276-291. PubMed ID: 35230161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal control for HIV treatment.
    Akudibillah G; Pandey A; Medlock J
    Math Biosci Eng; 2018 Dec; 16(1):373-396. PubMed ID: 30674124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and Control for HIV/AIDS Transmission in China Based on Data from 2004 to 2016.
    Li Z; Teng Z; Miao H
    Comput Math Methods Med; 2017; 2017():8935314. PubMed ID: 29312465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problem issues related to HIV/AIDS in Eastern European and Central Asian countries].
    Onishchenko GG
    Vestn Ross Akad Med Nauk; 2007; (9):20-6. PubMed ID: 18030715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Médicins sans Frontières HIV/AIDS programme in Ukraine].
    van den Berk GE; Telnov A; Venis SF; Mills CF; O'Brien DP
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2685-9. PubMed ID: 18179088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of different sexual-contact patterns between age classes on the predicted demographic impact of AIDS in developing countries.
    Anderson RM; Ng TW; Boily MC; May RM
    Ann N Y Acad Sci; 1989; 569():240-74. PubMed ID: 2698092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS in a new millennium.
    Schwartländer B; Garnett G; Walker N; Anderson R
    Science; 2000 Jul; 289(5476):64-6. PubMed ID: 10928930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS: an update.
    Harris A; Bolus NE
    Radiol Technol; 2008; 79(3):243-52; quiz 253-5. PubMed ID: 18203878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, evolution, and future of the HIV/AIDS pandemic.
    Levin BR; Bull JJ; Stewart FM
    Emerg Infect Dis; 2001; 7(3 Suppl):505-11. PubMed ID: 11485642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of HIV infection and AIDS in central African cities.
    Auvert B; Moore M; Bertrand WE; Beauchet A; Aegerter P; Lusamba D; Diong KT; Klinowski J
    Int J Epidemiol; 1990 Jun; 19(2):417-28. PubMed ID: 2376457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.
    Abbas UL; Anderson RM; Mellors JW
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):632-41. PubMed ID: 16652038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction.
    Sidibé M; Zuniga JM; Montaner J
    Clin Infect Dis; 2014 Jul; 59 Suppl 1(Suppl 1):S3-6. PubMed ID: 24926030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1999 Dec; 48(RR-13):1-27, 29-31. PubMed ID: 10632297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifurcation and optimal control analysis of HIV/AIDS and COVID-19 co-infection model with numerical simulation.
    Kotola BS; Teklu SW; Abebaw YF
    PLoS One; 2023; 18(5):e0284759. PubMed ID: 37146033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical Model of HIV/AIDS Considering Sexual Preferences Under Antiretroviral Therapy, a Case Study in San Juan de Pasto, Colombia.
    Espitia CC; Botina MA; Solarte MA; Hernandez I; Riascos RA; Meyer JF
    J Comput Biol; 2022 May; 29(5):483-493. PubMed ID: 35544039
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.